vimarsana.com
Home
Live Updates
KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomn
KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomn
KP1077 Is Safe, Tolerable for Improving Idiopathic Hypersomnia Symptoms
A phase 2 trial found KP1077 provides clinically meaningful benefits for idiopathic hypersomnia.
Related Keywords
United States ,
American ,
Christopher Drake ,
Henry Ford Health Christopher Drake ,
American Academy Of Sleep Medicine ,
Drug Administration ,
Us Drug Enforcement Agency ,
Henry Ford Health ,
Zevra Therapeutics ,
American Academy ,
Orphan Drug Designation ,
Enforcement Agency ,
Epworth Sleepiness Scale ,
Idiopathic Hypersomnia Severity Scale ,
Sleep Inertia Visual Analog Scale ,
Epworth Sleepiness ,
Brain Fog Severity Scale ,
Therapeutics Announces Top Line Data ,
Global News ,
Kind Indication ,
Chronic Sleep Disorder ,
Accessed March ,
Idiopathic Hypersomnia ,
Sleep ,
Sleep Problems ,
Excessive Sleepiness ,
Kp1077 ,
Serdexmethylphenidate ,